应化学化工学院、甘肃省有色金属化学与资源利用重点实验室邀请，美国芝加哥大学林文斌教授来我校进行交流并做学术报告，欢迎感兴趣的师生参加。

报 告 人：林文斌 教授

报告题目：Metal-organic Frameworks for Sustainable Catalysis and Cancer Therapy

报告时间：2019年9月18日（星期三）上午 9:00

报告地点：第二化学楼101学术报告厅

报告摘要：Metal-organic frameworks (MOFs) are an interesting class of crystalline molecular materials that are synthesized by combining metal-connecting points and bridging ligands. The modular nature of and mild conditions for MOF synthesis have permitted the rational structural design of numerous MOFs and the incorporation of various functionalities via constituent building blocks. The structure-property relationships of MOFs can also be readily established by taking advantage of the knowledge of their detailed atomic structures, which enables fine-tuning of their functionalities for desired applications. In this talk, I will discuss our recent efforts on designing MOFs for sustainable catalysis and cancer therapy.  MOFs have enabled the rational synthesis of single-site solid catalysts by not only facilitating the immobilization of known homogeneous catalysts but also allowing the discovery of new molecular catalysts that do not have homogeneous counterparts. Furthermore, we have demonstrated the ability to combine multiple treatment modalities into a single MOF nanoparticle for effective cancer therapy.

报告人简介：Dr. Wenbin Lin is the James Franck Professor of Chemistry, Radiation and Cellular Oncology, and the Ludwig Center for Metastasis Research, and Comprehensive Cancer Center at the University of Chicago. Lin obtained his BS from the University of Science and Technology in Hefei, China and his PhD from the University of Illinois at Urbana-Champaign. He was an NSF postdoctoral fellow with Professor Tobin J. Marks at Northwestern University. Lin focuses on designing molecular materials for sustainability and human health, and has published close to 350 peer-reviewed articles. He has been among the most cited chemists several years in a row and was selected as one of the top 10 chemists in the 1999-2009 decade based on per article citations. Dr. Lin is founder of two clinical stage biopharmaceutical companies and has received numerous professional honors for his contributions to functional molecular materials.